Leaders in Pharmaceutical Business Intelligence (LPBI) Group

What is the Direction of NEJM under the new Editor-in-Chief??

Reporter: Aviva Lev-Ari, PhD, RN

I read several Eulogies written for Arnold S. Relman.

Following the Death of Editor Arnold S. Relman, Jeffrey Drazen, Editor-in-Chief of the New England Journal of Medicine took the heavy helm.

How is it going so far??

Amid Public Feuds, A Venerated Medical Journal Finds Itself Under Attack

by Charles Ornstein
ProPublica, April 5, 2016, 8 a.m. – This story was co-published with The Boston Globe.

Ornstein writes:

The New England Journal of Medicine is arguably the best-known and most venerated medical journal in the world. Studies featured in its pages are cited more often, on average, than those of any of its peers. And the careers of young researchers can take off if their work is deemed worthy of appearing in it.

But following a series of well-publicized feuds with prominent medical researchers and former editors of the Journal, some are questioning whether the publication is slipping in relevancy and reputation. The Journal and its top editor, critics say, have resisted correcting errors and lag behind others in an industry-wide push for more openness in medical research. And dissent has been dismissed with a paternalistic arrogance, they say.

A compelling DRAMA is describing the time following the glorious reign of Editor Arnold S. Relman

CONTINUE TO READ

https://www.propublica.org/article/amid-public-feuds-a-venerated-medical-journal-finds-itself-under-attack